2009Hunan Agricultural SciencesRequires access

The Pharmacokinetic Comparison between Thiamphenicol and HP-β-CD Thiamphenicol in Rabbit

Jie Yu

Open publisher page 0 citations

Abstract

The pharmacokinetic regulations of thiamphenicol and HP-β-CD thiamphenicol were investigated by taken oral administration at a dosage of 30 mg/kg to healthy rabbits. The concentration of thiamphenicol in plasma was determined by RP-HPLC, and the data of concentration-time were analyzed by pharmacokinetic-compartment analysis soft(3P97). The data of concentration-time after oral administration of thiamphenicol and HP-β-CD thiamphenicol were all fitted to a one -compartment open model with first -order absorption. The main pharmacokinetic parameters of thiamphenicol were as follows: Lagtime(0. 05 ±0. 02)h, t1/ 2ka(0. 83 ±0. 02)h, t1/ 2ke(2.27 ±0. 31)h, T(peak) (1. 84 ±0. 12)h, C(max)(6. 98 ±0. 95)mg/ L, AUC(34. 98 ±0. 68)mg/(L·h)and F(110. 74 ±0. 02)%. The main pharmacokinetic parameters of HP-β-CD thiamphenicol were as follows: Lagtime (0. 02 ±0. 01) h, t1/2ka (0. 91 ± 0. 16) h, t1/2ke (0.86 ±0. 15) h, T(peak) (0.96 ±0. 07) h, C (max) (8.59 ±0. 55) mg/ L, AUC (43. 02 ±0. 87) mg/ (L·h), F (142.07 ±0. 02) %. The pharmacokinetic characteristics of HP-β-CD thiamphenicol in healthy rabbits manifested the rapid and complete absorption, wide distribution, rapid elimination and the high bioavailability by the oral routes.

About this research paper

What this paper is about

The pharmacokinetic regulations of thiamphenicol and HP-β-CD thiamphenicol were investigated by taken oral administration at a dosage of 30 mg/kg to healthy rabbits. The concentration of thiamphenicol in plasma was determined by RP-HPLC, and the data of concentration-time were analyzed by pharmacokinetic-compartment analysis soft(3P97). The data of concentration-time after oral administration of thiamphenicol and HP-β-CD thiamphenicol were all fitted to a one -compartment open model with first -order absorption. The main pharmacokinetic parameters of thiamphenicol were as follows: Lagtime(0. 05 ±0. 02)h, t1/ 2ka(0. 83 ±0. 02)h, t1/ 2ke(2.27 ±0. 31)h, T(peak) (1. 84 ±0. 12)h, C(max)(6. 98 ±0. 95)mg/ L, AUC(34. 98 ±0. 68)mg/(L·h)and F(110. 74 ±0. 02)%. The main pharmacokinetic parameters of HP-β-CD thiamphenicol were as follows: Lagtime (0. 02 ±0. 01) h, t1/2ka (0. 91 ± 0. 16) h, t1/2ke (0.86 ±0. 15) h, T(peak) (0.96 ±0. 07) h, C (max) (8.59 ±0. 55) mg/ L, AUC (43. 02 ±0. 87) mg/ (L·h), F (142.07 ±0. 02) %. The pharmacokinetic characteristics of HP-β-CD thiamphenicol in healthy rabbits manifested the rapid and complete absorption, wide distribution, rapid elimination and the high bioavailability by the oral routes.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The pharmacokinetic regulations of thiamphenicol and HP-β-CD thiamphenicol were investigated by taken oral administration at a dosage of 30 mg/kg to healthy rabbits. The concentration of thiamphenicol in plasma was determined by RP-HPLC, and the data of concentration-time were analyzed by pharmacokinetic-compartment analysis soft(3P97). The data of concentration-time after oral administration of thiamphenicol and HP-β-CD thiamphenicol were all fitted to a one -compartment open model with first -order absorption. The main pharmacokinetic parameters of thiamphenicol were as follows: Lagtime(0. 05 ±0. 02)h, t1/ 2ka(0. 83 ±0. 02)h, t1/ 2ke(2.27 ±0. 31)h, T(peak) (1. 84 ±0. 12)h, C(max)(6. 98 ±0. 95)mg/ L, AUC(34. 98 ±0. 68)mg/(L·h)and F(110. 74 ±0. 02)%. The main pharmacokinetic parameters of HP-β-CD thiamphenicol were as follows: Lagtime (0. 02 ±0. 01) h, t1/2ka (0. 91 ± 0. 16) h, t1/2ke (0.86 ±0. 15) h, T(peak) (0.96 ±0. 07) h, C (max) (8.59 ±0. 55) mg/ L, AUC (43. 02 ±0. 87) mg/ (L·h), F (142.07 ±0. 02) %. The pharmacokinetic characteristics of HP-β-CD thiamphenicol in healthy rabbits manifested the rapid and complete absorption, wide distribution, rapid elimination and the high bioavailability by the oral routes.

Key concepts: Thiamphenicol, Pharmacokinetics, Bioavailability, Absorption (acoustics), Pharmacology, Compartment (ship), Oral administration, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
The Pharmacokinetic Comparison between Thiamphenicol and HP-β-CD Thiamphenicol in Rabbit — Research Paper | ScholarLens